Top Story May 24, 2021 ISLAMABAD: The state-run National Institute of Health has begun the production of a single-dose Chinese coronavirus vaccine believing the initiative will help meet the country's vaccine needs. The officials told ‘The News’ that a total of 124,000 CanSino jabs had been developed with China’s support and they would be rolled out in local packaging in the current week. Pakistan was among the first countries to take part in the clinical trial of CanSino vaccine. Its local production comes after the successful clinical trial in the country. The officials said Chinese firm CanSino Biologics Inc had provided the NIH with the raw material and technology for vaccine production and even sent in experts to oversee the exercise.